Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Biosimilars to Amgen’s lucrative bone drugs Prolia and Xgeva triumphed at the FDA, though ongoing patent litigation makes the launch timing uncertain.
Fraiser Kansteiner
Mar 6, 2024 9:52am
Sandoz ponies up $265M to settle lingering price-fixing case
Feb 29, 2024 10:49am
House Democrats press Teva, Pfizer and Sandoz on drug shortages
Feb 22, 2024 10:44am
Sandoz to shutter Eon Labs site acquired nearly 20 years ago
Feb 8, 2024 1:56pm
Sandoz buys Coherus' Lucentis biosimilar Cimerli for $170M
Jan 22, 2024 11:55am
Novartis pawns off Indian ophthalmology brands to J.B. Pharma
Dec 20, 2023 10:01am